메뉴 건너뛰기




Volumn 6, Issue 3, 2011, Pages 489-507

Targeted nutlin-3a loaded nanoparticles inhibiting p53-MDM2 interaction: Novel strategy for breast cancer therapy

Author keywords

cancer therapy; MDM2 inhibition; nanoparticle; nutlin 3a; surface functionalization; targeted therapy

Indexed keywords

NANOPARTICLE; NUTLIN 3; POLYGLACTIN; PROTEIN MDM2; PROTEIN P53; TRANSFERRIN;

EID: 79955612431     PISSN: 17435889     EISSN: None     Source Type: Journal    
DOI: 10.2217/nnm.10.102     Document Type: Article
Times cited : (31)

References (56)
  • 1
    • 0034676455 scopus 로고    scopus 로고
    • Surfing the p53 network
    • Vogelstein B, Lane D, Levine AJ: Surfing the p53 network. Nature 408(6810), 307-310 (2000).
    • (2000) Nature , vol.408 , Issue.6810 , pp. 307-310
    • Vogelstein, B.1    Lane, D.2    Levine, A.J.3
  • 2
    • 0036674617 scopus 로고    scopus 로고
    • Live or let die: The cell's response to p53
    • DOI 10.1038/nrc864
    • Vousden KH, Lu X: Live or let die: The cell's response to p53. Nat. Rev. Cancer 2(8), 594-604 (2002). (Pubitemid 37328926)
    • (2002) Nature Reviews Cancer , vol.2 , Issue.8 , pp. 594-604
    • Vousden, K.H.1    Lu, X.2
  • 3
    • 0033992478 scopus 로고    scopus 로고
    • P53 and human cancer: The first ten thousand mutations
    • Hainaut P, Hollstein M: P53 and human cancer: The first ten thousand mutations. Adv. Cancer Res. 77, 81-137 (2000). (Pubitemid 29439303)
    • (2000) Advances in Cancer Research , vol.77 , pp. 81-137
    • Hainaut, P.1    Hollstein, M.2
  • 5
    • 0025853776 scopus 로고
    • Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line
    • Fakharzadeh SS, Trusko SP, George DL: Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line. EMBRO J. 10(6), 1565-1569 (1991). (Pubitemid 21905621)
    • (1991) EMBO Journal , vol.10 , Issue.6 , pp. 1565-1569
    • Fakharzadeh, S.S.1    Trusko, S.P.2    George, D.L.3
  • 6
    • 0027325132 scopus 로고
    • Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53
    • DOI 10.1038/362857a0
    • Oliner JD, Pietenpol JA, Thiagalingam S, Gyuris J, Kinzler KW, Vogelstein B: Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature 362(6423), 857-860 (1993). (Pubitemid 23132165)
    • (1993) Nature , vol.362 , Issue.6423 , pp. 857-860
    • Oliner, J.D.1    Pietenpol, J.A.2    Thiagalingam, S.3    Gyuris, J.4    Kinzler, K.W.5    Vogelstein, B.6
  • 7
    • 0032145989 scopus 로고    scopus 로고
    • The MDM2 gene amplification database
    • DOI 10.1093/nar/26.15.3453
    • Momand J, Jung D, Wilczynski S, Niland J: The MDM2 gene amplification database. Nucleic Acids Res. 26(15), 3453-3459 (1998). (Pubitemid 28347214)
    • (1998) Nucleic Acids Research , vol.26 , Issue.15 , pp. 3453-3459
    • Momand, J.1    Jung, D.2    Wilczynski, S.3    Niland, J.4
  • 8
    • 0030575937 scopus 로고    scopus 로고
    • Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain
    • DOI 10.1126/science.274.5289.948
    • Kussie PH, Gorina S, Marechal V et al.: Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain. Science 274(5289), 948-953 (1996). (Pubitemid 26398409)
    • (1996) Science , vol.274 , Issue.5289 , pp. 948-953
    • Kussie, P.H.1    Gorina, S.2    Marechal, V.3    Elenbaas, B.4    Moreau, J.5    Levine, A.J.6    Pavletich, N.P.7
  • 9
    • 0030905284 scopus 로고    scopus 로고
    • Mdm2 promotes the rapid degradation of p53
    • DOI 10.1038/387296a0
    • Haupt Y, Maya R, Kazaz A, Oren M: MDM2 promotes the rapid degradation of p53. Nature 387(6630), 296-299 (1997). n Provides information regarding the p53-MDM2 interaction and subsequent degradation of p53 following the proteasome degradation pathway. (Pubitemid 27220766)
    • (1997) Nature , vol.387 , Issue.6630 , pp. 296-299
    • Haupt, Y.1    Maya, R.2    Kazaz, A.3    Oren, M.4
  • 10
    • 0031583962 scopus 로고    scopus 로고
    • Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53
    • DOI 10.1016/S0014-5793(97)01480-4, PII S0014579397014804
    • Honda R, Tanaka H, Yasuda H: Oncoprotein MDM2 is a ubiquitin ligase e3 for tumor suppressor p53. FEBS Lett. 420(1), 25-27 (1997). (Pubitemid 28037193)
    • (1997) FEBS Letters , vol.420 , Issue.1 , pp. 25-27
    • Honda, R.1    Tanaka, H.2    Yasuda, H.3
  • 11
    • 0030965946 scopus 로고    scopus 로고
    • Regulation of p53 stability by Mdm2
    • DOI 10.1038/387299a0
    • Kubbutat MH, Jones SN, Vousden KH: Regulation of p53 stability by MDM2. Nature 387(6630), 299-303 (1997). (Pubitemid 27220767)
    • (1997) Nature , vol.387 , Issue.6630 , pp. 299-303
    • Kubbutat, M.H.G.1    Jones, S.N.2    Vousden, K.H.3
  • 12
    • 0029952441 scopus 로고    scopus 로고
    • In vivo ubiquitination and proteasome-mediated degradation of p53
    • Maki CG, Huibregtse JM, Howley PM: In vivo ubiquitination and proteasome-mediated degradation of p53(1). Cancer Res. 56(11), 2649-2654 (1996). (Pubitemid 26170702)
    • (1996) Cancer Research , vol.56 , Issue.11 , pp. 2649-2654
    • Maki, C.G.1    Huibregtse, J.M.2    Howley, P.M.3
  • 13
    • 0037329056 scopus 로고    scopus 로고
    • The p53-Mdm2 module and the ubiquitin system
    • DOI 10.1016/S1044-579X(02)00099-8, PII S1044579X02000998
    • Michael D, Oren M: The p53-MDM2 module and the ubiquitin system. Semin. Cancer Biol. 13(1), 49-58 (2003). (Pubitemid 36269180)
    • (2003) Seminars in Cancer Biology , vol.13 , Issue.1 , pp. 49-58
    • Michael, D.1    Oren, M.2
  • 16
    • 0033799839 scopus 로고    scopus 로고
    • Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs
    • Krishna R, Mayer LD: Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs. Eur. J. Pharm. Sci. 11(4), 265-283 (2000).
    • (2000) Eur. J. Pharm. Sci. , vol.11 , Issue.4 , pp. 265-283
    • Krishna, R.1    Mayer, L.D.2
  • 17
    • 58349112761 scopus 로고    scopus 로고
    • Reversal of p-glycoprotein-mediated multidrug resistance by the murine double minute 2 antagonist nutlin-3
    • Michaelis M, Rothweiler F, Klassert D et al.: Reversal of p-glycoprotein-mediated multidrug resistance by the murine double minute 2 antagonist nutlin-3. Cancer Res. 69(2), 416-421 (2009).
    • (2009) Cancer Res. , vol.69 , Issue.2 , pp. 416-421
    • Michaelis, M.1    Rothweiler, F.2    Klassert, D.3
  • 18
    • 0346848865 scopus 로고    scopus 로고
    • Nanotech approaches to drug delivery and imaging
    • DOI 10.1016/S1359-6446(03)02903-9, PII S1359644603029039
    • Sahoo SK, Labhasetwar V: Nanotech approaches to drug delivery and imaging. Drug Discov. Today 8(24), 1112-1120 (2003). (Pubitemid 37547917)
    • (2003) Drug Discovery Today , vol.8 , Issue.24 , pp. 1112-1120
    • Sahoo, S.K.1    Labhasetwar, V.2
  • 19
    • 0037462997 scopus 로고    scopus 로고
    • Biodegradable nanoparticles for drug and gene delivery to cells and tissue
    • DOI 10.1016/S0169-409X(02)00228-4
    • Panyam J, Labhasetwar V: Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv. Drug Deliv. Rev. 55(3), 329-347 (2003). (Pubitemid 36297053)
    • (2003) Advanced Drug Delivery Reviews , vol.55 , Issue.3 , pp. 329-347
    • Panyam, J.1    Labhasetwar, V.2
  • 20
    • 66149116471 scopus 로고    scopus 로고
    • Ligand-based targeted therapy for cancer tissue
    • Das M, Mohanty C, Sahoo SK: Ligand-based targeted therapy for cancer tissue. Expert Opin. Drug Deliv. 6(3), 285-304 (2009).
    • (2009) Expert Opin. Drug Deliv. , vol.6 , Issue.3 , pp. 285-304
    • Das, M.1    Mohanty, C.2    Sahoo, S.K.3
  • 21
    • 39449102666 scopus 로고    scopus 로고
    • Polymeric nanoparticles for cancer therapy
    • DOI 10.1080/10611860701794353, PII 790599771
    • Parveen S, Sahoo SK: Polymeric nanoparticles for cancer therapy. J. Drug Target 16(2), 108-123 (2008). (Pubitemid 351266548)
    • (2008) Journal of Drug Targeting , vol.16 , Issue.2 , pp. 108-123
    • Parveen, S.1    Sahoo, S.K.2
  • 22
    • 0036889760 scopus 로고    scopus 로고
    • Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway
    • DOI 10.1124/pr.54.4.561
    • Qian ZM, Li H, Sun H, Ho K: Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway. Pharmacol. Rev. 54(4), 561-587 (2002). (Pubitemid 35351196)
    • (2002) Pharmacological Reviews , vol.54 , Issue.4 , pp. 561-587
    • Qian, Z.M.1    Li, H.2    Sun, H.3    Ho, K.4
  • 23
    • 4544358907 scopus 로고    scopus 로고
    • Efficacy of transferrin-conjugated paclitaxel-loaded nanoparticles in a murine model of prostate cancer
    • DOI 10.1002/ijc.20405
    • Sahoo SK, Ma W, Labhasetwar V: Efficacy of transferrin-conjugated paclitaxel-loaded nanoparticles in a murine model of prostate cancer. Int. J. Cancer 112(2), 335-340 (2004). nn Demonstrates how a simple molecule transferrin can be used as a potent targeting agent to enhance the therapeutic efficacy of many neoplastic drugs. (Pubitemid 39244375)
    • (2004) International Journal of Cancer , vol.112 , Issue.2 , pp. 335-340
    • Sahoo, S.K.1    Ma, W.2    Labhasetwar, V.3
  • 24
    • 68749092564 scopus 로고    scopus 로고
    • Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy
    • Acharya S, Dilnawaz F, Sahoo SK: Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy. Biomaterials 30(29), 5737-5750 (2009).
    • (2009) Biomaterials , vol.30 , Issue.29 , pp. 5737-5750
    • Acharya, S.1    Dilnawaz, F.2    Sahoo, S.K.3
  • 25
    • 0042634190 scopus 로고    scopus 로고
    • Fluorescence and electron microscopy probes for cellular and tissue uptake of poly(D,L-lactide-co-glycolide) nanoparticles
    • DOI 10.1016/S0378-5173(03)00295-3
    • Panyam J, Sahoo SK, Prabha S, Bargar T, Labhasetwar V: Fluorescence and electron microscopy probes for cellular and tissue uptake of poly(d,l-lactide-co-glycolide) nanoparticles. Int. J. Pharm. 262(1-2), 1-11 (2003). (Pubitemid 36966688)
    • (2003) International Journal of Pharmaceutics , vol.262 , Issue.1-2 , pp. 1-11
    • Panyam, J.1    Sahoo, S.K.2    Prabha, S.3    Bargar, T.4    Labhasetwar, V.5
  • 26
    • 24144490885 scopus 로고    scopus 로고
    • Enhanced antiproliferative activity of transferrin-conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention
    • DOI 10.1021/mp050032z
    • Sahoo SK, Labhasetwar V: Enhanced antiproliferative activity of transferrin-conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention. Mol. Pharm. 2(5), 373-383 (2005). (Pubitemid 41503678)
    • (2005) Molecular Pharmaceutics , vol.2 , Issue.5 , pp. 373-383
    • Sahoo, S.K.1    Labhasetwar, V.2
  • 27
    • 51849085687 scopus 로고    scopus 로고
    • The intracellular uptake ability of chitosan-coated poly (d,l-lactide-co-glycolide) nanoparticles
    • Kim BS, Kim CS, Lee KM: The intracellular uptake ability of chitosan-coated poly (d,l-lactide-co-glycolide) nanoparticles. Arch. Pharm. Res. 31(8), 1050-1054 (2008).
    • (2008) Arch. Pharm. Res. , vol.31 , Issue.8 , pp. 1050-1054
    • Kim, B.S.1    Kim, C.S.2    Lee, K.M.3
  • 28
    • 48349102690 scopus 로고    scopus 로고
    • Magnetic nanoparticles with dual functional properties: Drug delivery and magnetic resonance imaging
    • Jain TK, Richey J, Strand M, Leslie-Pelecky DL, Flask CA, Labhasetwar V: Magnetic nanoparticles with dual functional properties: Drug delivery and magnetic resonance imaging. Biomaterials 29(29), 4012-4021 (2008).
    • (2008) Biomaterials , vol.29 , Issue.29 , pp. 4012-4021
    • Jain, T.K.1    Richey, J.2    Strand, M.3    Leslie-Pelecky, D.L.4    Flask, C.A.5    Labhasetwar, V.6
  • 30
    • 3042613166 scopus 로고    scopus 로고
    • Sustained cytoplasmic delivery of drugs with intracellular receptors using biodegradable nanoparticles
    • Panyam J, Labhasetwar V: Sustained cytoplasmic delivery of drugs with intracellular receptors using biodegradable nanoparticles. Mol. Pharm. 1(1), 77-84 (2004).
    • (2004) Mol. Pharm. , vol.1 , Issue.1 , pp. 77-84
    • Panyam, J.1    Labhasetwar, V.2
  • 31
    • 33746118057 scopus 로고    scopus 로고
    • Activation of mammalian target of rapamycin signaling pathway contributes to tumor cell survival in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma
    • DOI 10.1158/0008-5472.CAN-05-3018
    • Vega F, Medeiros LJ, Leventaki V et al.: Activation of mammalian target of rapamycin signaling pathway contributes to tumor cell survival in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma. Cancer Res. 66(13), 6589-6597 (2006). (Pubitemid 44085614)
    • (2006) Cancer Research , vol.66 , Issue.13 , pp. 6589-6597
    • Vega, F.1    Medeiros, L.J.2    Leventaki, V.3    Atwell, C.4    Cho-Vega, J.H.5    Tian, L.6    Claret, F.-X.7    Rassidakis, G.Z.8
  • 32
    • 34249894977 scopus 로고    scopus 로고
    • Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody
    • DOI 10.1016/j.jconrel.2007.03.012, PII S0168365907001472
    • Kocbek P, Obermajer N, Cegnar M, Kos J, Kristl J: Targeting cancer cells using plga nanoparticles surface modified with monoclonal antibody. J. Control Release 120(1-2), 18-26 (2007). (Pubitemid 46874614)
    • (2007) Journal of Controlled Release , vol.120 , Issue.1-2 , pp. 18-26
    • Kocbek, P.1    Obermajer, N.2    Cegnar, M.3    Kos, J.4    Kristl, J.5
  • 33
    • 0036955764 scopus 로고    scopus 로고
    • Intracellular drug delivery using poly(D,L-lactide-co-glycolide) nano-particles derivatized with a peptide from a transcriptional activator protein of HIV-1
    • DOI 10.1023/A:1021373731787
    • Nam YS, Park JY, Han SH, Chang IS: Intracellular drug delivery using poly(d,l-lactide-co-glycolide) nanoparticles derivatized with a peptide from a transcriptional activator protein of HIV-1. Biotechnology Lett. 24, 2093-2098 (2002). (Pubitemid 36093404)
    • (2002) Biotechnology Letters , vol.24 , Issue.24 , pp. 2093-2098
    • Nam, Y.S.1    Park, J.Y.2    Han, S.-H.3    Chang, I.-S.4
  • 34
    • 0037026269 scopus 로고    scopus 로고
    • Size-dependency of nanoparticle-mediated gene transfection: Studies with fractionated nanoparticles
    • DOI 10.1016/S0378-5173(02)00315-0, PII S0378517302003150
    • Prabha S, Zhou WZ, Panyam J, Labhasetwar V: Size-dependency of nanoparticle-mediated gene transfection: Studies with fractionated nanoparticles. Int. J. Pharm. 244(1-2), 105-115 (2002). (Pubitemid 35245451)
    • (2002) International Journal of Pharmaceutics , vol.244 , Issue.1-2 , pp. 105-115
    • Prabha, S.1    Zhou, W.-Z.2    Panyam, J.3    Labhasetwar, V.4
  • 35
    • 68249134353 scopus 로고    scopus 로고
    • Sustained antibacterial activity of doxycycline-loaded poly(d,l-lactide-co-glycolide) and poly(e-caprolactone) nanoparticles
    • Misra R, Acharya S, Dilnawaz F, Sahoo SK: Sustained antibacterial activity of doxycycline-loaded poly(d,l-lactide-co-glycolide) and poly(e-caprolactone) nanoparticles. Nanomedicine (Lond). 4(5), 519-530 (2009).
    • (2009) Nanomedicine (Lond). , vol.4 , Issue.5 , pp. 519-530
    • Misra, R.1    Acharya, S.2    Dilnawaz, F.3    Sahoo, S.K.4
  • 36
    • 67650090674 scopus 로고    scopus 로고
    • The in vitro sub-cellular localization and in vivo efficacy of novel chitosan/GMO nanostructures containing paclitaxel
    • Trickler WJ, Nagvekar AA, Dash AK: The in vitro sub-cellular localization and in vivo efficacy of novel chitosan/GMO nanostructures containing paclitaxel. Pharm. Res. 26(8), 1963-1973 (2009).
    • (2009) Pharm. Res. , vol.26 , Issue.8 , pp. 1963-1973
    • Trickler, W.J.1    Nagvekar, A.A.2    Dash, A.K.3
  • 37
    • 0037331856 scopus 로고    scopus 로고
    • Dynamics of endocytosis and exocytosis of poly(D,L-lactide-co-glycolide) nanoparticles in vascular smooth muscle cells
    • DOI 10.1023/A:1022219003551
    • Panyam J, Labhasetwar V: Dynamics of endocytosis and exocytosis of poly(d,l-lactide-co-glycolide) nanoparticles in vascular smooth muscle cells. Pharm. Res. 20(2), 212-220 (2003). (Pubitemid 36277684)
    • (2003) Pharmaceutical Research , vol.20 , Issue.2 , pp. 212-220
    • Panyam, J.1    Labhasetwar, V.2
  • 38
    • 28844485350 scopus 로고    scopus 로고
    • Expression of pro-apoptotic (p53, p21, bax, bak and fas) and anti-apoptotic (bcl-2 and bcl-x) proteins in serous versus mucinous borderline ovarian tumours
    • DOI 10.1002/jso.20424
    • Fauvet R, Dufournet C, Poncelet C, Uzan C, Hugol D, Darai E: Expression of pro-apoptotic (p53, p21, bax, bak and fas) and anti-apoptotic (bcl-2 and bcl-x) proteins in serous versus mucinous borderline ovarian tumours. J. Surg. Oncol. 92(4), 337-343 (2005). (Pubitemid 41779293)
    • (2005) Journal of Surgical Oncology , vol.92 , Issue.4 , pp. 337-343
    • Fauvet, R.1    Dufournet, C.2    Poncelet, C.3    Uzan, C.4    Hugol, D.5    Darai, E.6
  • 39
    • 22244443786 scopus 로고    scopus 로고
    • P53 activation by small molecules: Application in oncology
    • DOI 10.1021/jm058174k
    • Vassilev LT: P53 activation by small molecules: Application in oncology. J. Med. Chem. 48(14), 4491-4499 (2005). (Pubitemid 40993409)
    • (2005) Journal of Medicinal Chemistry , vol.48 , Issue.14 , pp. 4491-4499
    • Vassilev, L.T.1
  • 40
    • 67449164584 scopus 로고    scopus 로고
    • Restoration of p53 pathway by nutlin-3 induces cell cycle arrest and apoptosis in human rhabdomyosarcoma cells
    • Miyachi M, Kakazu N, Yagyu S et al.: Restoration of p53 pathway by nutlin-3 induces cell cycle arrest and apoptosis in human rhabdomyosarcoma cells. Clin. Cancer Res. 15(12), 4077-4084 (2009).
    • (2009) Clin. Cancer Res. , vol.15 , Issue.12 , pp. 4077-4084
    • Miyachi, M.1    Kakazu, N.2    Yagyu, S.3
  • 41
    • 0027989808 scopus 로고
    • Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis
    • Koopman G, Reutelingsperger CP, Kuijten GA, Keehnen RM, Pals ST, van Oers MH: Annexin v for flow cytometric detection of phosphatidylserine expression on b cells undergoing apoptosis. Blood 84(5), 1415-1420 (1994). (Pubitemid 24273007)
    • (1994) Blood , vol.84 , Issue.5 , pp. 1415-1420
    • Koopman, G.1    Reutelingsperger, C.P.M.2    Kuijten, G.A.M.3    Keehnen, R.M.J.4    Pals, S.T.5    Van Oers, M.H.J.6
  • 42
    • 0030941458 scopus 로고    scopus 로고
    • P53, the cellular gatekeeper for growth and division
    • DOI 10.1016/S0092-8674(00)81871-1
    • Levine AJ: P53, the cellular gatekeeper for growth and division. Cell 88(3), 323-331 (1997). (Pubitemid 27131374)
    • (1997) Cell , vol.88 , Issue.3 , pp. 323-331
    • Levine, A.J.1
  • 44
    • 0035862692 scopus 로고    scopus 로고
    • Taxane-antibody conjugates afford potent cytotoxicity, enhanced solubility, and tumor target selectivity
    • Guillemard V, Saragovi HU: Taxane-antibody conjugates afford potent cytotoxicity, enhanced solubility, and tumor target selectivity. Cancer Res. 61(2), 694-699 (2001). (Pubitemid 32140477)
    • (2001) Cancer Research , vol.61 , Issue.2 , pp. 694-699
    • Guillemard, V.1    Saragovi, H.U.2
  • 47
    • 0035755278 scopus 로고    scopus 로고
    • Resistant mechanisms of anthracyclines - pirarubicin might partly break through the p-glycoprotein-mediated drug-resistance of human breast cancer tissues
    • Kubota T, Furukawa T, Tanino H et al.: Resistant mechanisms of anthracyclines - pirarubicin might partly break through the p-glycoprotein- mediated drug-resistance of human breast cancer tissues. Breast Cancer 8(4), 333-338 (2001).
    • (2001) Breast Cancer , vol.8 , Issue.4 , pp. 333-338
    • Kubota, T.1    Furukawa, T.2    Tanino, H.3
  • 48
    • 0346670126 scopus 로고    scopus 로고
    • Clathrin and caveolin-1 expression in primary pigmented rabbit conjunctival epithelial cells: Role in PLGA nanoparticle endocytosis
    • Qaddoumi MG, Gukasyan HJ, Davda J, Labhasetwar V, Kim KJ, Lee VH: Clathrin and caveolin-1 expression in primary pigmented rabbit conjunctival epithelial cells: Role in PLGA nanoparticle endocytosis. Mol. Vis. 9, 559-568 (2003). (Pubitemid 38097623)
    • (2003) Molecular Vision , vol.9 , pp. 559-568
    • Qaddoumi, M.G.1    Gukasyan, H.J.2    Davda, J.3    Labhasetwar, V.4    Kim, K.-J.5    Lee, V.H.L.6
  • 49
    • 0036324712 scopus 로고    scopus 로고
    • Rapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: Implications for drug and gene delivery
    • DOI 10.1096/fj.02-0088com
    • Panyam J, Zhou WZ, Prabha S, Sahoo SK, Labhasetwar V: Rapid endo-lysosomal escape of poly(dl-lactide-co-glycolide) nanoparticles: Implications for drug and gene delivery. FASEB J. 16(10), 1217-1226 (2002). (Pubitemid 34815409)
    • (2002) FASEB Journal , vol.16 , Issue.10 , pp. 1217-1226
    • Panyam, J.1    Zhou, W.-Z.2    Prabha, S.3    Sahoo, S.K.4    Labhasetwar, V.5
  • 50
    • 27744508956 scopus 로고    scopus 로고
    • Paclitaxel-loaded PLGA nanoparticles: Potentiation of anticancer activity by surface conjugation with wheat germ agglutinin
    • DOI 10.1016/j.jconrel.2005.08.013, PII S0168365905003664
    • Mo Y, Lim LY: Paclitaxel-loaded PLGA nanoparticles: Potentiation of anticancer activity by surface conjugation with wheat germ agglutinin. J. Control Release 108(2-3), 244-262 (2005). (Pubitemid 41608658)
    • (2005) Journal of Controlled Release , vol.108 , Issue.2-3 , pp. 244-262
    • Mo, Y.1    Lim, L.-Y.2
  • 51
    • 0027496935 scopus 로고
    • The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin- dependent kinases
    • DOI 10.1016/0092-8674(93)90499-G
    • Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ: The p21 CDK-interacting protein CIP1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75(4), 805-816 (1993). (Pubitemid 23346377)
    • (1993) Cell , vol.75 , Issue.4 , pp. 805-816
    • Harper, J.W.1    Adami, G.R.2    Wei, N.3    Keyomarsi, K.4    Elledge, S.J.5
  • 52
    • 0028931265 scopus 로고
    • Principles of CDK regulation
    • Morgan DO: Principles of CDK regulation. Nature 374(6518), 131-134 (1995).
    • (1995) Nature , vol.374 , Issue.6518 , pp. 131-134
    • Morgan, D.O.1
  • 53
    • 0029033861 scopus 로고
    • The retinoblastoma protein and cell cycle control
    • Weinberg RA: The retinoblastoma protein and cell cycle control. Cell 81(3), 323-330 (1995).
    • (1995) Cell , vol.81 , Issue.3 , pp. 323-330
    • Weinberg, R.A.1
  • 54
    • 0027717617 scopus 로고
    • P21 is a universal inhibitor of cyclin kinases
    • DOI 10.1038/366701a0
    • Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D: P21 is a universal inhibitor of cyclin kinases. Nature 366(6456), 701-704 (1993). (Pubitemid 24036020)
    • (1993) Nature , vol.366 , Issue.6456 , pp. 701-704
    • Xiong, Y.1    Hannon, G.J.2    Zhang, H.3    Casso, D.4    Kobayashi, R.5    Beach, D.6
  • 55
    • 68749114554 scopus 로고    scopus 로고
    • Inhibition of apoptosis through localized delivery of rapamycin-loaded nanoparticles prevented neointimal hyperplasia and reendothelialized injured
    • Reddy MK, Vasir JK, Sahoo SK, Jain TK, Yallapu MM, Labhasetwar V: Inhibition of apoptosis through localized delivery of rapamycin-loaded nanoparticles prevented neointimal hyperplasia and reendothelialized injured. Circ. Cardiovasc. Intervent. 1, 209-216 (2008).
    • (2008) Circ. Cardiovasc. Intervent. , vol.1 , pp. 209-216
    • Reddy, M.K.1    Vasir, J.K.2    Sahoo, S.K.3    Jain, T.K.4    Yallapu, M.M.5    Labhasetwar, V.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.